Legislation relating to cannabis use and possession: definitions and overview of the situation in Europe

 

eisaiow3.jpg

Memo, OFDT, 10 p.
Mars 2016

The laws governing cannabis use, tolerated in some countries yet totally banned in others, vary significantly from one European Union country to another. However, the terms used in the debate are often not fully understood. Despite being regularly employed in public forums, the concepts of liberalisation, legalisation, depenalisation, decriminalisation and classification as a petty offence do not always have a commonly accepted definition.

Developed drawing on the references cited in the bibliography and with the help of legal experts and researchers specialising in penal matters, this note firstly presents a lexicon assembling a few proposals for the definition of the main terms used in the recurrent debates relative to the legal status of cannabis. This is followed by an overview of current legislation concerning cannabis use and possession in France and Europe, along with a comparison of the most significant legislative changes outside Europe.

Author : Ivana Obradovic

Download the PDF file (25 Ko)

 

 

 

 

 

 

 

 

Drugs in Europe


2021 EMCDDA European Drug Report

COVID-19
How is the COVID-19 pandemic affecting drug use, supply and services?
Drug use and harms
What are the health costs of drug use in Europe today?
Drug markets
What do the latest data tell us about drug production and trafficking trends?

These and other questions are explored in the 2021 European Drug Report, our annual overview of the drug situation in Europe.

  Statistical Bulletin 2021

The annual Statistical Bulletin contains the most recent available data on the drug situation in Europe provided by the Member States. These datasets underpin the analysis presented in the European Drug Report. All data may be viewed interactively on screen and downloaded in Excel format..

The European Union and the drug phenomenon

miniFAQDrugsEurope.jpgThe European Union & the drug phenomenon : Frequently asked questions, joint publication between the EMCDDA and the European Commission, october 2010, 12 p.